Details for New Drug Application (NDA): 211581
✉ Email this page to a colleague
The generic ingredient in TRIAMTERENE is hydrochlorothiazide; triamterene. There are thirty-two drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; triamterene profile page.
Summary for 211581
Tradename: | TRIAMTERENE |
Applicant: | Agnitio |
Ingredient: | triamterene |
Patents: | 0 |
Pharmacology for NDA: 211581
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Medical Subject Heading (MeSH) Categories for 211581
Suppliers and Packaging for NDA: 211581
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TRIAMTERENE | triamterene | CAPSULE;ORAL | 211581 | ANDA | TRUPHARMA LLC | 52817-364 | 52817-364-10 | 100 CAPSULE in 1 BOTTLE (52817-364-10) |
TRIAMTERENE | triamterene | CAPSULE;ORAL | 211581 | ANDA | TRUPHARMA LLC | 52817-365 | 52817-365-10 | 100 CAPSULE in 1 BOTTLE (52817-365-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Aug 19, 2019 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Aug 19, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription